During the past decade, Psychiatric Centers at San Diego conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Psychiatric Centers at San Diego" are "Attention Deficit Hyperactivity Disorder (ADHD)" (3 trials), "Attention-Deficit/Hyperactivity Disorder" (3 trials), "Fragile X Syndrome" (2 trials), "ADHD" (1 trials) and "Attention Deficit Hyperactivity Disorder" (1 trials). Many other conditions were trialed in "Psychiatric Centers at San Diego" in a lesser frequency.

Most popular intervention types in "Psychiatric Centers at San Diego" are "Drug" (11 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Extended-release Guanfacine Hydrochloride" (3 trials), "Atomoxetine Hydrochloride" (2 trials), "SPD489" (2 trials) and "arbaclofen" (2 trials). Other intervention names were less common.

The vast majority of trials in "Psychiatric Centers at San Diego" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Psychiatric Centers at San Diego". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Psychiatric Centers at San Diego, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Psychiatric Centers at San Diego, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".